You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 1, 2026

Profile for San Marino Patent: T202400030


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for San Marino Patent: T202400030

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,300,054 Aug 23, 2031 Alkermes Inc LYBALVI olanzapine; samidorphan l-malate
10,716,785 Aug 23, 2031 Alkermes Inc LYBALVI olanzapine; samidorphan l-malate
11,185,541 Aug 23, 2031 Alkermes Inc LYBALVI olanzapine; samidorphan l-malate
11,241,425 Aug 23, 2031 Alkermes Inc LYBALVI olanzapine; samidorphan l-malate
11,351,166 Aug 23, 2031 Alkermes Inc LYBALVI olanzapine; samidorphan l-malate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for San Marino Drug Patent SMT202400030

Last updated: August 5, 2025


Introduction

San Marino’s patent SMT202400030 signifies a strategic patent securing exclusive rights for a pharmaceutical compound or formulation. Analyzing its scope, claims, and broader patent landscape is imperative for stakeholders such as pharmaceutical companies, legal professionals, and investors to understand its competitive positioning, patent strength, and potential overlaps within the relevant therapeutic domain.

This report provides a comprehensive, technical evaluation of SMT202400030, emphasizing its scope and claims while outlining the landscape context within which the patent operates.


Patent Scope and Overview

SMT202400030 is a patent filed in San Marino that encompasses a pharmaceutical invention; although limited publicly available details constrain deciphering exact compound specifics, the patent typically covers an innovative drug compound, a therapeutic method, or a specific formulation.

Claims Overview

The claims form the core of the patent, defining its legal boundaries and scope of exclusivity. They are categorized as independent claims, which broadly encapsulate the invention, and dependent claims, which refine, specify, or narrow the scope.

Although the detailed claims of SMT202400030 are not publicly accessible in this context, similar pharmaceutical patents generally have:

  • Composition Claims: Covering specific chemical entities, salts, polymorphs, or formulations.
  • Method of Use Claims: Encompassing therapeutic applications or treatment methods.
  • Process Claims: Detailing manufacturing steps or synthesis pathways.

The breadth of these claims determines the patent’s strength; broader claims extend protection but may face freedom-to-operate challenges for some competitors, whereas narrower claims may be easier to design around.

Scope Analysis

Given typical pharmaceutical patent strategies, SMT202400030 likely claims an innovative molecule or a specific formulation with enhanced efficacy, stability, or bioavailability. The scope probably encompasses:

  • Chemical scope: A unique chemical structure or a novel derivative.
  • Functional scope: Methods for treating specific diseases or conditions.
  • Formulation scope: Specific excipients or delivery mechanisms.

The claim language likely emphasizes the novelty and inventive step over prior art, such as previous compounds or formulations disclosed in the public patent literature or scientific literature.


Patent Landscape and Strategic Context

1. Patent Families and Related IP

  • Related Patent Families: It is common for pharmaceutical patents to be part of wider patent families that include secondary filings (e.g., PCT, European, US patents), protecting different jurisdictions.
  • Secondary Patents: These may include method-of-use patents, polymorph patents, or dosage patents to extend exclusivity.

2. Competitor and Innovation Landscape

The landscape surrounding SMT202400030 involves prior patents covering related compounds, known drug classes, or therapeutic methods. Noteworthy adjacent patents could include:

  • Chemical Class Patents: Covering similar molecular frameworks.
  • Treatment Patents: Covering related therapeutic indications.
  • Formulation Patents: Covering proprietary delivery systems.

Patent clearance and freedom-to-operate analyses are vital, ensuring that SMT202400030 does not infringe existing rights and identifying potential licensing opportunities.

3. Overlap and Potential Challenges

  • Prior Art Search: The scope's novelty hinges on differentiations from published literature, existing patents, and scientific disclosures.
  • Patentability Concerns: Overly broad claims that overlap with known compounds might be challenged or invalidated.
  • Patent Term and Extension: The typical 20-year patent term applies, with potential extensions if applicable (e.g., data exclusivity, SPC).

Legal and Commercial Implications

Regulatory Strategies:

  • Patents like SMT202400030 can be pivotal during regulatory submissions for exclusivity while seeking marketing authorization.
  • They serve as barriers to competitors, incentivizing R&D investment.

Market Positioning:

  • Securing robust claims enhances market dominance.
  • Licensing discussions hinge on patent scope and strength.

Enforcement and Litigation:

  • Precise claim language influences assertability.
  • Broad claims provide leverage but may invite validity challenges.

Comparison with Global Patent Landscape

San Marino, as a microstate, often relies on filings in larger jurisdictions; hence, alignment with global patent strategies is pivotal.

  • International Applications: It is crucial to determine if SMT202400030 has corresponding filings under PCT or in larger markets like the EU or US.
  • Patent Portfolio Alignment: The patent’s value skyrockets if integrated into a broader, multi-jurisdictional patent family covering key markets and indications.

Conclusion

SMT202400030’s scope likely encompasses a novel pharmaceutical compound or formulation with claims narrowly tailored to demonstrate inventive features over prior art. Its positioning within a larger patent landscape depends on related filings, market needs, and competitor patents. The strength and enforceability of its claims will significantly determine its commercial value and legal standing.


Key Takeaways

  • Claim Breadth Critical: Broad independent claims maximize protection but require careful novelty and inventive step consideration.
  • Landscape Integration: Effective patent strategy involves aligning SMT202400030 with related patents internationally.
  • Competitor Awareness: Monitoring relevant prior art and potential overlapping patents ensures proactive IP management.
  • Regulatory and Commercial Strategy: Patent stability supports exclusive marketing rights, incentivizing investments in commercialization.
  • Legal Vigilance: Precise, defensible claims reduce infringement risk and enhance enforceability.

FAQs

  1. What is the typical scope of pharmaceutical patents like SMT202400030?
    Such patents generally cover new chemical entities, formulations, or methods of use, with claims tailored to demonstrate novelty, inventive step, and industrial applicability.

  2. How does the patent landscape influence the value of SMT202400030?
    A dense landscape with overlapping patents can limit scope; however, a unique invention with broad claims provides stronger market exclusivity and licensing leverage.

  3. Can SMT202400030 be challenged or invalidated?
    Yes. If prior art demonstrates the invention lacks novelty or inventive step, the patent can face validity challenges during opposition procedures.

  4. What is the importance of related patent families?
    They expand geographical coverage, protect various aspects (such as process, formulation, or use), and prolong market exclusivity.

  5. What should be considered for global patent protection?
    Aligning filings across PCT, USPTO, EPO, and other jurisdictions ensures comprehensive protection and mitigates infringement risks.


Sources

[1] World Intellectual Property Organization (WIPO) Patent Database.
[2] European Patent Office (EPO) Public Patent Data.
[3] USPTO Patent Full-Text and Image Database.
[4] Global Patent Landscape Reports on Pharmaceutical Innovations.
[5] San Marino Patent Office Official Records (if accessible).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.